Pacific Biosciences Of California (PACB) EPS (Diluted) Growth (5y) (2019 - 2026)
Pacific Biosciences Of California (PACB) EPS (Diluted) Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pacific Biosciences Of California | 428.15 Mn | 152.18 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.65% |
| Dec 31, 2025 | -18.27% |
| Sep 30, 2025 | 2.33% |
| Jun 30, 2025 | 23.31% |
| Mar 31, 2025 | -46.07% |
| Dec 31, 2024 | 15.60% |
| Sep 30, 2024 | -3.18% |
| Jun 30, 2024 | -30.92% |
| Mar 31, 2024 | -6.56% |
| Dec 31, 2023 | -6.93% |
| Sep 30, 2023 | 17.68% |
| Jun 30, 2023 | 2.53% |
| Mar 31, 2023 | 11.92% |
| Dec 31, 2022 | -10.35% |
| Sep 30, 2022 | -1.93% |
| Jun 30, 2022 | 1.54% |
| Mar 31, 2022 | 13.57% |
| Dec 31, 2021 | -10.82% |
| Jun 30, 2021 | -13.02% |
| Mar 31, 2021 | 4.59% |